Company profile: Evidation
1.1 - Company Overview
Company description
- Provider of a platform that measures health in everyday life and enables anyone to participate in research and health programs, built on user privacy and control over permissioned health data. Through its Achievement platform, trusted by millions, it generates data with unprecedented speed, scale, and rigor to support better health outcomes.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Evidation
360 Vantage
HQ: United States
Website
- Description: Provider of cloud-based CRM, sales force automation, and closed-loop marketing systems for the life sciences industry, offering 360 CRM, 360 CLM, compliance and e-learning solutions, along with a full suite of professional and managed services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full 360 Vantage company profile →
Gene Logic
HQ: United States
Website
- Description: Provider of comprehensive Genomic Reference Databases and GLP-compliant Microarray Services as part of an integrated genomics offering, serving over two-thirds of the top 25 pharma companies, leading research institutes, and emerging biotech companies worldwide.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gene Logic company profile →
Market Access Transformation
HQ: United States
Website
- Description: Provider of an online platform and associated services that enable healthcare manufacturers and payers to exchange market access insights via surveys and clarification requests. Offerings include Rapid Payer Response (RPR), Manufacturer and Payer Portals, a global network of vetted healthcare stakeholders (Payer Network), Agile Payer Research, and payer insights on the acceptability of surrogate endpoints in clinical trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Market Access Transformation company profile →
Deep Genomics
HQ: Canada
Website
- Description: Provider of an AI platform that analyzes RNA biology, identifies novel targets, and evaluates therapeutic candidates; BigRNA, the first RNA foundation model for RNA therapeutics that discovers new biological mechanisms and RNA therapeutic candidates; and BigRNA+, which expands BigRNA to include more genetic mechanisms and diseases for broader therapeutic discovery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Deep Genomics company profile →
Intelligent Pharma
HQ: Spain
Website
- Description: Provider of computational technologies for drug discovery and related services, offering computational chemistry services to pharmaceutical companies, biotech companies and research institutes; now part of Mind the Byte.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Intelligent Pharma company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Evidation
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Evidation
2.2 - Growth funds investing in similar companies to Evidation
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Evidation
4.2 - Public trading comparable groups for Evidation
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →